| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 77, 644-646, Copyright © 1993 by Endocrine Society
ARTICLES |
VL Cryns, JM Alexander, A Klibanski and A Arnold
Endocrine Unit, Massachusetts General Hospital, Boston.
Functional inactivation of the retinoblastoma (RB) tumor suppressor gene is important in the pathogenesis of many human tumors. Recently, the frequent occurrence of pituitary tumors was reported in mice genetically engineered to have one defective RB allele, a genetic background analogous to that of patients with familial retinoblastoma. The molecular pathogenesis of human pituitary tumors is largely unknown, and the potential role of RB gene inactivation in these neoplasms has not been examined. Consequently, we studied 20 human pituitary tumors (12 clinically nonfunctioning tumors, 4 somatotroph adenomas, 2 prolactinomas, and 2 corticotroph adenomas) for tumor- specific allelic loss of the RB gene using a highly informative polymorphic locus within the gene. Control leukocyte DNA samples from 18 of these 20 patients were heterozygous at this locus, permitting genetic evaluation of their paired tumor specimens. In contrast to the pituitary tumors in the mouse model, none of these 18 human tumors exhibited RB allelic loss. These findings indicate that RB gene inactivation probably does not play an important role in the pathogenesis of common types of human pituitary tumors.
This article has been cited by other articles:
 |
|
 |
|
  X. Zhu, X. Mao, R. Hurren, A. D. Schimmer, S. Ezzat, and S. L. Asa Deoxyribonucleic Acid Methyltransferase 3B Promotes Epigenetic Silencing through Histone 3 Chromatin Modifications in Pituitary Cells J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3610 - 3617. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ezzat, X. Zhu, S. Loeper, S. Fischer, and S. L. Asa Tumor-Derived Ikaros 6 Acetylates the Bcl-XL Promoter to Up-Regulate a Survival Signal in Pituitary Cells Mol. Endocrinol., November 1, 2006; 20(11): 2976 - 2986. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. P. Heaney Pituitary tumour pathogenesis. Br. Med. Bull., January 1, 2006; 75-76: 81 - 97. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. A. Kaltsas, P. Nomikos, G. Kontogeorgos, M. Buchfelder, and A. B. Grossman Diagnosis and Management of Pituitary Carcinomas J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 3089 - 3099. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Caliumi, G. De Toma, A. Bossini, R. Cianci, C. Bosman, M. Genuardi, S. Cerci, and C. Letizia A rare combination consisting of aldosterone-producing adenoma and adrenal myelolipoma in a patient with heterozygosity for retinoblastoma (RB) gene Journal of Renin-Angiotensin-Aldosterone System, March 1, 2004; 5(1): 45 - 48. [Abstract] [PDF]
|
|
|
|
 |
|
 D. J. Simpson, N. A. Hibberts, A. M. McNicol, R. N. Clayton, and W. E. Farrell Loss of pRb Expression in Pituitary Adenomas Is Associated with Methylation of the RB1 CpG Island Cancer Res., March 1, 2000; 60(5): 1211 - 1216. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. G. Pestell, C. Albanese, A. T. Reutens, J. E. Segall, R. J. Lee, and A. Arnold The Cyclins and Cyclin-Dependent Kinase Inhibitors in Hormonal Regulation of Proliferation and Differentiation Endocr. Rev., August 1, 1999; 20(4): 501 - 534. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. L. M. Dahia and A. B. Grossman The Molecular Pathogenesis of Corticotroph Tumors Endocr. Rev., April 1, 1999; 20(2): 136 - 155. [Abstract] [Full Text]
|
|
|
|
|
|
D. J. Simpson, J. Magnay, J. E. Bicknell, A. L. Barkan, A. M. McNicol, R. N. Clayton, and W. E. Farrell Chromosome 13q Deletion Mapping in Pituitary Tumors: Infrequent Loss of the Retinoblastoma Susceptibility Gene (RB1) Locus Despite Loss of RB1 Protein Product in Somatotrophinomas Cancer Res., April 1, 1999; 59(7): 1562 - 1566. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Asa and S. Ezzat The Cytogenesis and Pathogenesis of Pituitary Adenomas Endocr. Rev., December 1, 1998; 19(6): 798 - 827. [Abstract] [Full Text]
|
|
|
|
|
|
I. Shimon and S. Melmed Pituitary Tumor Pathogenesis J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1675 - 1681. [Full Text] [PDF]
|
|
|
|
|
|
L. Pei and S. Melmed Isolation and Characterization of a Pituitary Tumor-Transforming Gene (PTTG) Mol. Endocrinol., April 1, 1997; 11(4): 433 - 441. [Abstract] [Full Text]
|
|
|
|
|
|
S. A. A. Abbass, S. L. Asa, and S. Ezzat Altered Expression of Fibroblast Growth Factor Receptors in Human Pituitary Adenomas J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1160 - 1166. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Bates, W. E. Farrell, E. J. Bicknell, A. M. McNicol, A. J. Talbot, J. C. Broome, C. W. Perrett, R. V. Thakker, and R. N. Clayton Allelic Deletion in Pituitary Adenomas Reflects Aggressive Biological Activity and Has Potential Value as a Prognostic Marker J. Clin. Endocrinol. Metab., March 1, 1997; 82(3): 818 - 824. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. L. Cryns, A. Thor, H.-J. Xu, S.-X. Hu, M. E. Wierman, A. L. Vickery, W. F. Benedict, and A. Arnold Loss of The Retinoblastoma Tumor-Suppressor Gene in Parathyroid Carcinoma N. Engl. J. Med., March 17, 1994; 330(11): 757 - 761. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
